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Abstract
Background: Autocrine & paracrine signaling are widespread both in vivo and in vitro, and are particularly important in
embryonic stem cell (ESC) pluripotency and lineage commitment. Although autocrine signaling via fibroblast growth factor-
4 (FGF4) is known to be required in mouse ESC (mESC) neuroectodermal specification, the question of whether FGF4
autocrine signaling is sufficient, or whether other soluble ligands are also involved in fate specification, is unknown. The
spatially confined and closed-loop nature of diffusible signaling makes its experimental control challenging; current
experimental approaches typically require prior knowledge of the factor/receptor in order to modulate the loop. A new
approach explored in this work is to leverage transport phenomena at cellular resolution to downregulate overall diffusible
signaling through the physical removal of cell-secreted ligands.
Methodology/Principal Findings: We develop a multiplex microfluidic platform to continuously remove cell-secreted
(autocrine\paracrine) factors to downregulate diffusible signaling. By comparing cell growth and differentiation in side-by-
side chambers with or without added cell-secreted factors, we isolate the effects of diffusible signaling from artifacts such as
shear, nutrient depletion, and microsystem effects, and find that cell-secreted growth factor(s) are required during
neuroectodermal specification. Then we induce FGF4 signaling in minimal chemically defined medium (N2B27) and inhibit
FGF signaling in fully supplemented differentiation medium with cell-secreted factors to determine that the non-FGF cell-
secreted factors are required to promote growth of differentiating mESCs.
Conclusions/Significance: Our results demonstrate for the first time that flow can downregulate autocrine\paracrine
signaling and examine sufficiency of extracellular factors. We show that autocrine\paracrine signaling drives
neuroectodermal commitment of mESCs through both FGF4-dependent and -independent pathways. Overall, by
uncovering autocrine\paracrine processes previously hidden in conventional culture systems, our results establish
microfluidic perfusion as a technique to study and manipulate diffusible signaling in cell systems.
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Introduction
Autocrine and paracrine signaling are widespread both in vivo
and in vitro, regulating events as diverse as tumor formation and
outgrowth [1], mammalian embryogenesis [2,3], and embryonic
stem cell (ESC) pluripotency and lineage commitment [4,5]. The
spatially confined and closed-loop nature of autocrine and
paracrine signaling—more generally referred to here as diffusible
or soluble signaling—makes its experimental control challenging
[6]. Although current experimental approaches allow known
ligand-receptor interactions to be induced (e.g., by adding soluble
ligand or overexpressing receptor) or blocked (e.g., blocking
antibodies [7], small molecule inhibitors [8], receptor/ligand
knockdowns or knockouts [9,10,11]), these specific approaches are
not capable of altering diffusible signaling when the ligand/
receptor pair is unknown. Altering cell density and assaying for
density-dependent phenotypes is a non-specific approach com-
monly used to identify new loops [5,12]. However, autocrine\-
paracrine loops that are sufficiently active in isolated cells may not
display density-dependent phenotypes as the cell density is varied
because density can only be increased above the single-cell level,
further saturating the loop [6]. In order to study such loops
nonspecifically, one requires a method that can effectively decrease
ligand concentration to below the single-cell level.
Recently, microtechnologies have emerged that offer more
precise control over cell-cell interactions. For instance, micro-
patterning of cells can control local cell density and hence alter
diffusible signaling [13], as can use of microchannels where flow is
suppressed [14], thus increasing diffusible signaling. These
approaches can productively modulate diffusible signaling, but
they cannot downregulate such signaling to below the single-cell
level, and with both of these approaches diffusible signaling will
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e22892increase over time as cells proliferate and signaling molecules
accumulate. Conversely, microfluidic flow can be used to tune the
relative importance of convection, diffusion and reaction [15], and
is thus ideally suited to address questions where one wishes to
study diffusible signaling by removing rather than augmenting ligand,
such as to study tight loops.
Here we apply microfluidic perfusion to identify the existence of
diffusible signaling loops in ESC processes previously hidden in
conventional assays. Several reviews [16,17,18,19] and prior work
have suggested the use of microfluidic flow to alter and minimize
autocrine\paracrine signaling [20] or to probe dose-dependent
responses [21] from known exogenous factors while using
perfusion to wash away cell-secreted factors, and transport models
suggest that it is possible to use convection to alter extracellular
ligand concentrations [22,23]. However, to date there has been no
clear demonstration of perturbing autocrine\paracrine signaling
via flow in a biologically significant manner, nor has flow been
used to elucidate diffusible signaling in stem cell biology.
ESCs are one biological system that illustrates both the impor-
tance of and challenges present in studying diffusible signaling.
ESCs are being widely investigated both for their potential
therapeutic applications (e.g., regenerative medicine) and as in vitro
models of development. Their utility depends in large part on our
ability to control their fate decisions in vitro. One important fate
choice is that of neural specification. mESCs can be readily
differentiated into neuronal cells using external factors including
retinoic acid [24] or Sonic hedgehog agonists [25]. mESCs can
also differentiate into neural precursors in adherent monoculture
in serum-free defined medium in the absence of the self-renewal
factors leukemia inhibitory factor (LIF) and bone morphogenetic
protein 4 (BMP4) [5]. In a study by Ying et al. [5] and follow-up
studies [10,26], researchers found that neuroectodermal differen-
tiation is not a default path, but rather that there is an obligate
requirement for FGF4, typically produced by the cells themselves
in an autocrine fashion, in the initiation of differentiation leading
to neuroectodermal specification. This autocrine loop is sufficient-
ly active at clonal density, as isolated mESCs are competent to
form neural precursors [5,12,27]. Although no other autocrine\-
paracrine loops have been identified in neuroectodermal specifi-
cation of mESCs, it is not known whether the FGF4 loop is the
only such loop active in this process; in other words, whether
FGF4 autocrine signaling is sufficient for neural specification of
mESCs.
Making use of flow we have, for the first time, examined the
question of sufficiency of FGF4 signaling in generating neuroec-
todermal precursors. We find that the primary role of FGF sig-
naling is in acquiring neuroectodermal identity and that another
autocrine\paracrine loop is required for growth during differen-
tiation, leading to the conclusion that FGF4 is not sufficient for
creating neuroectoderm. Our results demonstrate that perfusion
can remove cell-secreted factors and affect diffusible signaling to
the extent that significant effects on cell fate are observed. These
findings establish microfluidic perfusion culture as a valuable
method for investigating autocrine and paracrine signaling in
biology.
Results
Device design
To modulate diffusible signaling, we developed a microfluidic
perfusion platform that subjects cells to continuous medium flow
while washing away cell-secreted factors (Figure 1A–B). The two-
layer device incorporates multiple culture chambers and normally
closed valves [28] that allow selective seeding of stem cells into
culture chambers only and permit cell attachment in the absence
of flow (Figure S1, S2). Active integrated bubble traps [29] prevent
failure due to bubble introduction, permitting robust long-term
culture of mammalian stem cells. We designed the microfluidic
chambers to be 250 mm high and used a perfusion flow-rate of
33 mL/hr, which we have previously shown [30] is sufficient for
robust growth of mESCs. The device culture chambers have a
mirror symmetry design with the respect to the cell input to ensure
balanced cell loading. Selective seeding of cells only into the
culture chambers provides a well-defined culture system that
Figure 1. Microfluidic system. A. Image of the microfluidic perfusion device, showing the upper pneumatic control layer (green), the two sets of
triplicate culture chambers (red and blue). B. Schematic of the perfusion device. Gray and purple outlines represent fluidic and control layer,
respectively. C. Microfluidic perfusion systems use flow to fine-tune the relative significance of convection, diffusion, and reaction.
doi:10.1371/journal.pone.0022892.g001
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that would otherwise be present in the fluid path upstream of
culture chambers. Additionally, the cell loading path bypasses the
integrated bubble traps, which are inline with the media inputs, to
avoid cell settling in large areas due to the reduced fluid velocity
present there (Figure S1). After loading, closing the valves to shut
off fluid flow eases cell attachment for challenging cell types like
ESCs. Finally, the multiple chambers are arranged to allow two
conditions to be run side-by-side, enabling the use of controls to
remove artifacts due to microscale perfusion culture. Together,
these features are critical for the use of microfluidic platform
in studying diffusible signaling, and contribute to the overall
robustness of the perfusion system.
Qualitative transport modeling
The ability to control the soluble cellular microenvironment is
enabled by the properties of microscale fluid flow, specifically the
ability to tune the relative importance of convective, diffusive, and
reactive transport (Figure 1C). In order to use perfusion to alter
diffusible signaling, one must operate in a regime where the rate of
convection of ligand dominates over the rates of diffusion and
reaction (i.e, ligand binding), which can be estimated by the ratio of
the dimensionless Pe ´clet number, Pe, and Damko ¨hler number, Da
(note that we actually refer to the Damko ¨hler group II [31],
though we will use the more generic term Damko ¨hler number
since it is the only one used in this manuscript). We explored
whether a typical cytokine/growth factor such as FGF-4 could be
swept away in microfluidic perfusion. FGF-4 has a MW of
,20 kDa and an estimated diffusivity DL,10
26–10
27 cm
2/s,
which we obtained from standard scaling arguments for the
diffusivity of macromolecules of different molecular weights [32].
To choose a conservative value that would, if anything, under-
estimate the importance of convection in relation to diffusion, we
use DL at the higher end of the range (,10
26 cm
2/s).
We first examined the relative significance of convective and
diffusive transport, as parameterized by the non-dimensional
Pe ´clet number, Pe=nmeanh/DL, where Pe&1 denotes convection-
dominated transport (Figure 1C). Here, nmean is the mean fluid
velocity in the chamber (,0.03 mm/s), and h denotes the
characteristic length in the system, which we take as the chamber
height (250 mm). For these values, we find that Pe<75, indicative
of convection-dominated transport. This velocity and chamber
height in turn imply a cell surface shear stress of ,3610
23 dyn/
cm
2, accounting for flow perturbations due to the presence of
attached cells [33]. This shear is at least 1006 lower than the
minimum values reported to adversely affect ESC developmental
potential or used in differentiation of mESCs in previous work
[34,35,36].
To include ligand binding in our estimate, we employ the
Damko ¨hler number, Da~konRSh=DL, which compares the
relative significance of ligand binding (i.e., reaction) and diffusion
of the ligand, where kon is the binding constant and Rs is the
receptor density. The number of FGF receptors per cell varies for
different cell types from 700 receptors per cell in mouse myoblast
MM14, to 20000 and 30000 receptors per cell for mouse 3T3
fibroblasts and mouse C3H10T1/2, respectively [37]; we chose as
a reasonable estimate 10000 receptors/cell and a radius of the
attached cells <10 mm. Values of ligand-receptor binding constant
kon vary greatly among ligand-receptor pairs, but prior measure-
ments of binding of FGF ligands with their receptors have
obtained values of kon of 4.2610
5 M
21 s
21 for FGF2 binding to
basement membrane [38], 1.4610
5 M
21 s
21 for FGF10 binding
to FGFR2 [39], and 2.0610
5 M
21 s
21 for FGF1 binding to
FGFR3c [40]. We chose a conservative estimate for kon of
10
6 M
21 s
21 (.26higher than literature values), which would if
anything overestimate the importance of ligand binding (and in
turn decrease the importance of convection). These parameter
choices result in Da,0.132, implying that diffusion dominates over
reaction. The ratio of these two dimensionless numbers, Pe and Da,
will estimate the relative significance of convective and reactive
transport, and we find that Pe/Da will be &1( ,500), implying
that microfluidic perfusion has the ability to suppress to a large
extent diffusible cell signaling. We emphasize that these nondi-
mensional parameter estimates do not prove that convection will
remove cell-secreted factors from the system, but merely provide
motivation and guidelines for system design.
Effects of perfusion on neuroectodermal specification
To investigate the role of cell-secreted factors in neuroectoder-
mal differentiation of mESCs, we differentiated cells to neuroec-
toderm in serum-free conditions, using a Sox1-GFP
+ (46C) mESC
cell line to report on differentiation status, where Sox1 is the
earliest known marker of neuroectoderm in the mouse embryo
[41]. mESC neuroectodermal differentiation is well-suited for
study of diffusible signaling using perfusion because (1) chemically-
defined (serum-free) self-renewal and neuroectodermal differenti-
ation conditions have been identified [42], avoiding confounding
effects of the unknown factors introduced by serum; (2) the cells
can be cultured and differentiated in adherent monoculture
consisting of ,2–3 layers of cells, giving the fluid flow easy access
to the cell surface for altering transport; (3) fluorescent reporter cell
lines are readily available, in contrast to human ESC cultures; (4)
the existence of the FGF4 autocrine loop required for neuroec-
todermal differentiation provides a test case for the microsystem;
and (5) biological insights derived from mESCs can often be
applied to hESCs. Cells cultured in static conditions in dishes had
by day 6 undergone differentiation into Sox1-GFP
+ neural
precursors, as expected [5] (Figure 2A). In contrast, cells cultured
at equivalent areal densities in microfluidic perfusion in the same
medium (N2B27) had very few cells by day 6 (Figure 2B).
The lack of growth in the perfused N2B27 condition could be
due to alteration of the diffusible environment, shear-induced
growth alteration, or some artifact due to culture in the micro-
system (such as nutrient depletion). To examine these possibilities,
we supplemented the N2B27 medium with cell-secreted factors
obtained from the differentiating cultures (N2B27+conditioned
medium (CM)). CM was conditioned in static dishes, and collected
on day 3 after LIF withdrawal, which temporally correlates with
the initial emergence of neural precursors, and dialyzed against
fresh media to compensate for changes in the small-molecule
fraction of the media, i.e., due to nutrient depletion. The resulting
CM would have the same nutrient concentrations as fresh media
and similar volume- and time-average secreted molecule concen-
trations as the static control. Use of this media rescued the ability
of the cells to grow and differentiate (Figure 2C–D). Additionally,
cells perfused with CM attained similar morphology, Sox1-GFP
levels, and Sox1 mRNA expression as static controls differentiated
in N2B27 (Figure 2E–G), and did not preferentially differentiate
into non-ectodermal lineages (Figure S3A) or self-renew (Figure
S3B). Because cells perfused in both N2B27 and N2B27+CM
experienced the same shear and nutrient delivery and are grown in
the same microsystem, the difference in outcomes strongly
precludes a role for shear stress, nutrient delivery, or microsystem
artifact in our results, and strongly suggests that the microfluidic
system is indeed sweeping away cell-secreted factors, which are
then reintroduced in the CM. Further, these results argue for the
presence of autocrine and/or paracrine factor(s) that contribute to
growth of differentiating mESC cultures, i.e., mESC differentiation
Microfluidic Control of Diffusible Signaling
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factors, but rather requires cell-secreted factors. Notably, these
diffusible factor(s) do not have anti-neurogenic activity, since in
our cultures they are added continuously over 5–7 days of
differentiation and not only promote growth of cells (Figure 2C),
but also result in a frequency of Sox1 expression comparable to
that of mESCs differentiated in static conditions in N2B27 (Figure
2E). Thus, our results provide strong evidence that microfluidic
perfusion can alter diffusible signaling to affect neuroectodermal
differentiation of mESCs.
Sufficiency of FGF4 signaling during neuroectodermal
differentiation
In examining which autocrine\paracrine loops might be being
perturbed in perfusion, we first focused on FGF4, a cell-secreted
factor known to be required for neuroectodermal specification.
Figure 2. Monoculture neuroectodermal differentiation and comparison of differentiation in static and perfusion systems. (A–C)
Schematic of culture conditions and images of 46C mESCs in different culture conditions taken 24 hours after seeding (left), and 6 days after
attachment (middle and right) for (A) static differentiating cultures in N2B27 medium, (B) on-chip perfused culture in N2B27 medium, and (C) on-chip
perfused culture in N2B27 medium with conditioned medium (CM). D. Fold increase in cell area after 5 days of perfusion culture for two different
conditions, N2B27 and N2B27+CM. Data are average 6 s.d. of 3 independent experiments. E. Analysis of Sox1 protein level - frequency of Sox1-GFP
+
cells after 7 days of differentiation for N2B27+CM (perfusion culture) and N2B27 condition (static culture), assessed via flow cytometry. Data are
average 6 s.d. of 3 independent experiments. F. Analysis of gene expression for N2B27+CM condition in perfusion culture - relative Sox1 gene
expression for N2B27+CM (perfusion culture) on Day 7 of differentiation normalized to GAPDH and gene expression level of Sox1 for N2B27 condition
(static culture). Data are average 6 s.d. of 2 independent experiments. 46C mESCs in self-renewal condition (N2B27+LIF+BMP4) were used as a
negative control for both flow cytometry and qRT-PCR analysis, (* indicates P,0.05; *** indicates P,0.001). G. Representative phase images of mESCs
colonies undergoing differentiation for three days in static and perfused cultures.
doi:10.1371/journal.pone.0022892.g002
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observed that blocking FGF signaling (by a small molecule FGF
receptor inhibitor (FGFRi) - PD173074) in both static culture
conditions N2B27 and N2B27+CM reduced differentiation but
not growth (Figure S4), as others have observed [5]. As these static
experiments block only FGF signaling while leaving all other
diffusible signaling active, they cannot elucidate whether addi-
tional (non-FGF) autocrine\paracrine loops are also involved in
neural specification.
To investigate whether additional loops are involved, we
supplemented N2B27 with FGF4 in perfused cultures, using
N2B27+CM as a positive control. Cells initially attached at similar
amounts in both conditions (for instance, for one representative
experiment the attachment area was ,7.5% (60.87%) of the total
chamber area for N2B27+FGF4 cultures and ,7.3% (62.3%) for
N2B27+CM cultures 24 hours after seeding). On days 1 and 2,
cells appeared to grow similarly in both conditions (Figure 3A),
and exhibited similar morphologies that were distinct from the
morphology of cells grown in self-renewal (Figure 3A). By day 3,
however, cell growth in the presence of FGF4 started to deviate
from that in the CM-supplemented condition (Figure 3A–B), and
by day 5 cell growth in N2B27+CM was more than 6-fold greater
than in N2B27+FGF4 (Figure 3B); FGF4 supplementation thus
failed to rescue growth of long-term cultures on chip. Increasing
the concentration of FGF4 4-fold did not restore growth under
perfusion (Figure 3B). These data strongly suggest that FGF4 is not
sufficient for promoting growth of differentiating mESCs to
neuroectoderm, and suggest an important role for other cell-
Figure 3. FGF signaling in perfusion culture. A. Phase images and close-ups of representative mESC colonies growing under differentiation and
self-renewal conditions. Representative images of time-course changes in mESC morphology under two differentiation conditions in perfusion
culture (N2B27+FGF4 and N2B27+CM) (left) or under self-renewal conditions in static culture (serum+LIF) (right). B. FGF4 supplementation in perfused
mESC differentiation. Growth curves for cells differentiated in N2B27+CM vs. N2B27+FGF4 (5, 20 ng/mL) in perfusion for 5 days. Data shown are
average 6 s.d. of 2 independent experiments for each FGF4 concentration (* Indicates P,0.05). (C–D) Inhibition of FGF signaling in perfused mESC
differentiation cultures. C. Transmission images of cells cultured in perfusion for 6 days in N2B27+CM and N2B27+CM+FGFRi (300 ng/mL) (left).
Growth analysis for cells cultured in the presence of FGFRi at 300 ng/mL. Fold increase in cell area after 5 days of perfusion culture for two different
conditions, N2B27+CM and N2B27+CM+FGFRi (right). D. Fluorescence images of cells cultured in perfusion for 6 days in N2B27+CM and
N2B27+CM+FGFRi (300 ng/mL) (left). Sox1-GFP
+ cell frequency assessed by flow cytometry for cells differentiated in N2B27+CM and
N2B27+CM+FGFRi condition on Day 6 of perfusion culture (right). Data are average 6 s.d. of 3 independent experiments, (*** Indicates P,0.001).
doi:10.1371/journal.pone.0022892.g003
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specification.
Time course of action of diffusible factors
To determine whether these other soluble factors in CM act on
both growth and differentiation or only growth or differentiation,
we blocked FGFR signaling under perfusion. We added the
FGFRi PD173074 to cells cultured in N2B27+CM in perfusion at
concentrations known to inhibit differentiation in static cultures
(Figure S4A–B), and compared growth and Sox1 expression to
control perfused cultures in N2B27+CM without the inhibitor.
After 6 days of perfusion, cells in both conditions reached con-
fluency (Figure 3C), demonstrating that inhibiting FGF signaling
did not significantly affect growth of mESCs. However, there was
a significant decrease in the frequency of Sox1-GFP positive cells
when we added the FGFR inhibitor (Figure 3D, Figure S5). These
results confirm that the role of FGF4 in the process of neuro-
ectodermal specification of mESCs is primarily tied to the regu-
lation of differentiation and acquiring neuroectodermal identity,
and show that the other ligands in CM are responsible for survival
or growth.
Recent evidence suggests that ESCs attain a neural fate in two
stages, first progressing thru an epiblast-like ‘‘primed’’ stage and
then to Sox1
+ neural precursors [43], reminiscent of the in vivo
transition from ICM to epiblast to neuroectoderm. Since pro-
gression through the epiblast-like stage occurs ,2–3 days into
differentiation, which is approximately when we observe differ-
ences between CM-supplemented and unsupplemented medium
(Figure 3A–B), we investigated the possibility that the requirement
for these non-FGF cell-secreted factors occurs for cells in an
epiblast-like state. Indeed, cells obtained from cultures 3 days in
perfusion had downregulation in self-renewal markers Klf4 and
Rex1 and upregulation of epiblast markers Fgf5, T, Sox17, and
Dnmt3b [44,45,46,47,48] (Figure 4), which is supportive of this
two-stage model. Together, our findings suggest a scenario where
diffusible factors act downstream of FGF4-induced lineage
commitment to regulate the growth of committed cells (Figure 5).
Discussion
We have utilized microfluidic perfusion to investigate the role of
autocrine and paracrine signaling in cellular decision processes,
and specifically in the differentiation of mESCs into neuroecto-
dermal precursors. Underlying this approach is the concept that
microfluidic perfusion allows operation in a convection-dominated
transport regime. Although it is likely that not all cell-secreted
factors are fully swept away in flow-based systems, even in
convection-dominated transport (because the Pe number is not
infinite and because binding of cell-secreted factors to extracellular
matrix can compete with convection), our results show that
perfusion can significantly alter diffusible signaling. The fact that
cells in perfusion culture did not survive under culture conditions
with reduced soluble factors (N2B27), whereas supplementing
N2B27 with cell-secreted factors (N2B27+CM) both fully recov-
ered growth as well as allowed differentiation into neuroectoderm,
point to a role for diffusible factor(s) in sustaining mESC growth in
neuroectodermal differentiation. We then examined whether
previously identified autocrine FGF4 was the causative agent
being removed in perfusion by studying two extremes: supplementing
minimal medium N2B27 with FGF4, and inhibiting FGF signaling
in fully supplemented medium (N2B27+CM). These results
strongly suggest that FGF4 does not act alone, that other
autocrine\paracrine factors are involved in cell growth during
differentiation. To our knowledge, our results identifying the
existence of another autocrine\paracrine loop in neural specifica-
tion are the first instance that microfluidic perfusion has been used
to demonstrate a biologically relevant outcome in a cell system
operating under conditions of reduced autocrine\paracrine
signaling.
Interpreting results obtained using microfluidic perfusion re-
quires care because of possible confounding factors. First, because
the surface-area-to-volume ratio of the microchambers (4/mm)
Figure 4. Gene expression profiling of committed mESCs in
perfusion. Relative expression of genes expressed in mESCs (Klf4,
Rex1) and epiblast (Sox17, Dnmt3b, T, Fgf5) for cells in perfusion culture
(N2B27+FGF4 at 5 ng/mL), normalized to GAPDH and to self-renewal
static culture (N2B27+LIF+BMP4). Data are shown as average 6 s.d.
from 4 independent experiments, (* Indicates statistical significance,
u P=0.06, * P,0.05, ** P,0.01, *** P,0.001 for logarithmic
distribution). The large variability in FGF5 gene expression is typical
for this gene [26].
Figure 5. Graphical model of signaling in mESC neuroectoder-
mal differentiation. Removing cell-secreted factors suppresses
growth and differentiation, which can be restored by supplementing
N2B27 medium with cell-secreted factors. Supplementation with (cell-
secreted) FGF4 does not rescue growth of perfused mESC cultures,
while inhibition of FGF signaling downregulates differentiation without
compromising mESC growth.
doi:10.1371/journal.pone.0022892.g005
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10-cm dish), plating cells at the same areal density in both systems
will result in a higher cell volumetric density in the microsystem
[49], potentially leading to nutritional artifacts. These can be
avoided by perfusing fast enough to adequately feed the cells, but
typifies the challenge in interpreting phenotypic differences be-
tween conventional static and perfused microfluidic (or static
microfluidic) cultures, and is the reason why the different pheno-
types observed in Figure 2A versus Figure 2B cannot be easily
ascribed to a cause.
The other confounding issue is that of shear stress. The
convection needed to alter diffusible signaling brings along fluid
shear, which can affect cell phenotype [34,35,36]. Operating
at shear stresses %1 dyn/cm
2 (here we use 0.003 dyn/cm
2),
significantly below those known to affect cell phenotype, helps
reduce the likelihood of shear stress effects. Perhaps the best way to
disambiguate the effects of shear from soluble signaling, though, is
through the use of perfusion with CM (e.g., Figure 2C). By
comparing outcomes between experiments with the same flow-rate
but different soluble environments (Figure 2B vs. Figure 2C), the
difference in observed phenotypes can be attributed to the
absence\presence of the soluble signals. The primary caveats in
interpreting CM experiments are that (1) failure to restore pheno-
type with a CM experiment does not prove that diffusible signaling
is not important, because short-lived soluble factors may not
survive in CM and because the CM contains the average ligand
concentrations, which may be different (and generally lower) that
those present locally in the static culture system, and (2) it is
formally possible that the phenotype observed with perfused CM is
due to the combination of shear and restored soluble factors. In
our experiments, since we are able to restore phenotype with CM
(Figure 2C), the first issue is not of concern. Additionally, it is
unlikely that our restored differentiation (Figure 2C) is due to the
combined action of shear and diffusible signaling because the
phenotype is qualitatively and quantitatively similar to that
observed in the absence of shear (Figure 2E–G); since soluble
factors with shear (Figure 2C) and soluble factors without shear
(Figure 2A) have similar phenotypes, the likeliest explanation is
that shear has negligible effect in our system.
Instead of CM experiments as performed here, one could
alternatively use a recirculating loop to let the cells condition the
media directly, however (1) recirculating loops are difficult to
construct at the microscale because the loop volume needs to be
similar to the culture volume (,12 ml), and (2) recirculating loops
do not allow for media exchange and as a result nutrients may
become limiting. Thus, observed phenotypes in recirculating loop
experiments could be due to diffusible signaling and/or metabolic
processes. Similarly, experiments that vary flow-rate as a means to
vary diffusible signaling also vary nutrients and shear, making it
difficult to disentangle the contributions of diffusible signaling from
other effects. Thus, CM experiments, when they are able to restore
phenotype, provide the cleanest experimental interpretation.
Our findings suggesting that FGF4 is not the sole cell-secreted
factor responsible for neuroectodermal specification, but rather
that other factors are involved in promoting growth during dif-
ferentiation, are consistent with the previous reports regarding the
distinct roles of FGF4 in promoting proliferation and differenti-
ation of embryonic stem cells and their differentiated progenies.
Kunath et al. used a variety of mESC knockout lines and small
molecule inhibitors to identify FGF4 as a pivotal activator of
Erk1/2 signaling in undifferentiated mESCs, and showed that
inhibition of Erk1/2 or FGFR signaling did not disturb the
expansion of undifferentiated ES cells but rather impaired their
ability to commit to neural and mesodermal lineages [10]. Wilder
et al. derived FGF4
2/2 mESCs and also reported no requirement
for FGF4 for growth of mESCs, but noted reduced numbers of
differentiated cells when mESCs were cultured in the absence of
FGF [50]. They ascribed this result to a growth-supportive
paracrine effect of FGF4 on differentiated cells, but in light of
more recent results [10,26], this could also be due to differential
growth of differentiating mESCs versus mESCs with a block in
neural commitment. Thus, current understanding is that FGF4
has no effect on mESC growth or self-renewal, but is important for
initiation of differentiation into neuroectoderm [51]. However,
these studies do not examine sufficiency of diffusible FGF4 sig-
naling, as they do not remove all autocrine\paracrine signaling,
leaving open the possibility that FGF4 acts in concert with other
factors in promoting this process.
The presence of non-FGF autocrine\paracrine loop(s) has thus
far been obscured in traditional culture settings, even though
robust neural differentiation protocols have existed for .15 years
[24] and are employed routinely in the literature. Because neural
differentiation is successful at clonal density in static culture
[5,12,27], any autocrine\paracrine loops involved are sufficiently
active at clonal density (including the FGF4 autocrine loop in
mESCs, which is almost fully saturated at clonal density [5]). Thus,
the effects of these loops would not be observed by varying plating
density, because if a single-cell produces enough ligand to activate
the loop, then increasing cell density would only increase the
ligand concentration and would not reveal their existence.
Similarly, the use of CM in static culture mimics increased density
and will be similarly uninformative. Instead, one way to approach
this question in static culture would be to develop a loss-of-
function screen (e.g., RNAi) to identify factors required for neuro-
ectodermal specification, and follow-up studies of hits could
pinpoint factors acting in an autocrine\paracrine fashion.
More generally, our results demonstrate the utility of perfusion
as a biophysical tool to interrogate diffusible signaling in a more
defined culture setting, complementing existing approaches that
modulate known autocrine\paracrine loops, using ligand addition
(e.g., FGF4 supplementation) and receptor inhibition (e.g., FGFRi).
Because perfusion nonspecifically disrupts diffusible signaling, it
allows for more stringent identification of sufficiency of extrinsic
factors for cell processes than is possible in a static culture.
Together, these methods constitute a useful screening strategy to
identify candidate cell-secreted molecules by sequential subtrac-
tion/inhibition of signaling molecules in fully supplemented
medium and addition of the same signaling molecules to puta-
tive minimal/sufficient medium. Beyond stem cell biology, the
methodology we present offers a novel tool for studying other
autocrine\paracrine systems, and could serve as a screening
strategy for identifying the cohort of extrinsic molecules involved
in diverse cellular processes.
Materials and Methods
Microfluidic perfusion device
The microfluidic perfusion device is a two-layer PDMS device
that consists of a fluidic layer (the bottom layer sealed to the
cell attachment substrate) controlled by normally closed valves
actuated via a pneumatic layer (the top layer). The pneumatic
layer consists of 100 mm-high displacement chambers connected
with 100 mm-high channels that can selectively be actuated with
vacuum (valves opened), or pressure (valves closed). The fluidic
layer consists of two bubble traps, two sets of three 250 mm-
high613000 mm-long61250 mm-wide cell culture chambers, and
corresponding flow-rate setting resistor channels at the outlet of
the chambers (100 mm width6100 mm height) of the same length
Microfluidic Control of Diffusible Signaling
PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e22892to achieve equal flow-rate distribution across the different
chambers. Fluid paths are altered by selectively actuating different
valve combinations throughout different stages of the experiment
(Figure 1B, Figure S1).
3-D AutoCad drawings were used to generate 3-D plastic molds
of the pneumatic and fluidic layer (Fineline, NC). Before device
fabrication, molds were silanized for 24 h in a vacuum chamber
with tridecafluoro-1,2,2-tetrahydrooctyl)-1-tricholorosilane (T2492-
KG, UnitedChemical Technologies, PA). Polydimethylsiloxane
(PDMS, Sylgard 184, Dow Corning, Midland, MI) was poured
onto both featured molds (10:1 ratio of prepolymer base to curing
agent). After pouring PDMS, the fluidic layer was covered with a
transparency film and then the entire assembly was placed between
two aluminum plates and clamped. This, along with designed
250 mm high cell culture chambers, and the support pillars (500 mm
height) ensured the overall thickness of the fluidic layer to be
500 mm, and those of cell culture chambers and the actuating
membrane to be half the size (250 mm). Both PDMS layers were left
overnight to cure at 65uC, and removed from the molds afterwards.
The featured side of the pneumatic layer (with the displacement
chambers) and blank side of the fluidic layer were plasma cleaned
(PDC-001, Harrick Plasma, Ithaca, NY), manually aligned, and
bonded together. The assembled device was left overnight at 65uC
to thermally strengthen the bond. Pneumatic connections were
punctured through the pneumatic layer only before bonding, using
thin-walled tubing (0.070 od60.06530 id, Small Parts Inc.). Fluidic
connections were punctured through both layers, using the same
tubing, after the bonding.
Perfusion experiments: Device setup and perfusion
culture
A sterile device was sealed to a sterile tissue culture polystyrene
slide (260225, Ted Pella, Inc., Redding, CA), and clamped into a
custom-designed microscope stage using three adjustable alumi-
num clamps (Figure S6A). A custom-made acrylic plate was added
in-between the PDMS device and aluminum clamps to ensure
equal pressure distribution and avoid collapse of the fluidic and
pneumatic channels under clamping pressure. It also ensured a
proper sealing of a device keeping the valves functional and
avoiding any fluidic leakage. Sterile tubing (UpChurch Scientific,
WA) was connected to the two media inputs, 4-way valve and
tubing to the cell input, and 4 tubings connecting outlets to the
waste tubes (Figure S6B).
A device was primed with 0.1% gelatin to insure bubble free
device for cells loading and to have cell culture chambers coated
with the gelatin to promote cell attachment. The following day,
the device was firstly perfused with a culture medium to avoid
perfusing on-chip cell culture with 0.1% gelatin and deprive cells
from nutrients in the beginning of perfusion culture, placed on an
automated inverted microscope fitted with a stage incubator (In
Vivo Scientific, St. Louis, MO), preheated to 37uC. Cells were
dissociated, counted and transferred to a 3 mL syringe (309585,
BD plastic), and loaded manually applying gentle pressure to cells-
filled syringe and while keeping valves of culture chambers open
and those on a fluidic path of cells to the culture chambers (see
Figure S1 for valve combinations used throughout different stages
of the experiment). Culture chambers were closed, and a pressure
of ,1 psi was applied to ensure valve sealing while flushing the
rest of a device with media from syringes connected to the two
media inlets (this procedure restricted cell growth to the cell
chambers only). After the loading procedure, cells were left for
about 30 minutes to settle down in chambers, and imaged using
Metamorph software; and the device was moved to the incubator
(37uC, 7.5% CO2) overnight to allow for cell attachment. During
the attachment period all the valves were left normally relaxed
(closed) to prevent any fluid movement in the device that could
potentially have an adverse effect on cell attachment. Perfusion
was resumed ,24 hours after seeding. Ten images (phase and/
or fluorescence) were acquired per chamber (3 chambers per
condition), and used in subsequent image analysis. The media
syringes filled with corresponding fresh media, were mounted on a
syringe pump (Harvard Apparatus Pump 11 Pico Plus) outside the
incubator and set to constant flow-rate of 0.1 mL/hr (,33 L mL/
hr per chamber). Filters (PN 4612 25 mm syringe filters with
0.2 mm membrane) were combined inline with the media inlet
tubing to maintain sterility while device being disconnected for
imaging and served as large bubble traps as well. The device
culture chambers were imaged daily during each experiment (up
to 5–7 days of perfusion culture depending on the experiment),
and cells were harvested from the chip on the last day for
subsequent flow cytometry or qRT-PCR analysis.
Cell culture
Sox1-GFP knock-in (46C) mESCs, developed by Austin Smith’s
group [5], were routinely propagated without feeders in leukemia
inhibitory factor (10 ng/ml, ESG1107, Chemicon, Temecula,
CA)-supplemented GMEM-based ESmedium:GMEM (11710035,
Invitrogen, Carlsbad, CA), 10% ES-qualified fetal bovine serum
(SH30070.03,Hyclone), 100 mM-mercaptoethanol (M7522, Sigma,
St. Louis, MO), and 50 U/mL penicillin, 50 mg/mL streptomycin
(15140122, Invitrogen). We cultured cells directly on tissue-culture
plastic (150679, Nunc) in a 37uC humidified environment with
7.5% CO2. For maintenance of 46C culture, we dissociated cells in
TrypLE Express (12604013, Invitrogen) every other day, and fed in
days between.
Neuronal differentiation
For monoculture differentiation undifferentiated mESCs were
dissociated, spun down, resuspended into LIF supplemented
differentiation medium (N2B27), and replated onto 0.1% gelatin
(ES-006-B Embryomax ES qualified gelatin, Millipore)-coated
tissue culture plastic dishes. Cells were plated at a density of 0.5–
1.0610
4 cells/cm
2 (both static and on-chip culture unless noted
otherwise) in N2B27+LIF (LIF was added the first day to promote
attachment, as others have done [27]). Cells were allowed to
attach for ,24 hours, washed twice with PBS (Phosphate Buffered
Saline, 14190 Invitrogen) to remove residual LIF and transferred
to N2B27 alone, or containing growth factors (FGF4 – fibroblast
growth factor, 235-F4 Recombinant Human FGF-4, R&D
systems), and inhibitor (FGFR inhibitor, PD173074, Calbiochem).
After LIF removal, medium was replaced every other day (N2B27,
N2B27+FGF4) or every day (FGFR inhibitor PD173074). This
protocol was applied to static cultures only. Perfusion cultures
were perfused constantly in all the different culture conditions,
with a single daily interruption during the image acquisition.
Conditioned medium preparation
Cells were plated onto 0.1% gelatin-coated dishes (168381,
Nunc) following the protocol for neuronal differentiation. Medium
was collected from cells undergoing neuronal differentiation on
day 3 after LIF removal. To account for possible nutrient
depletion, collected medium was spun down for ,45 minutes at
,3200 g (manufacturer’s directions) using Amicon Ultra centrif-
ugal filter unit with a 3 kDa filter (UFC900324, Millipore) until
reduced to ,3% of its original volume, then supplemented with
fresh N2B27 media to reach the original volume. We focused on
the large-molecule fraction of the medium (.3 kDa), as that
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(cytokines).
Image acquisition and processing
All the images were acquired on an inverted microscope (Zeiss
Axiovert 200 M, Thornwood, NY) using a 106objective with an
automated stage (Ludl MAC 5000, Hawthorne, NY). We used
Metamorph imaging software (Molecular Devices, Downingtown,
PA) to acquire the raw images, which were later processed using
Matlab (Mathworks, Natick, MA). Fluorencence images were
acquired with FITC filter set using an ImagerQE camera
(LaVision). Exposure time was set up using GFP negative ES cells
(D3 cell line, used as well as a negative control for flow cytometry),
making sure to always use the same exposure when comparing
different conditions from the same experiment. Cell growth was
determined by quantifying the fold increase in cell spreading area
at a given time point over the initial area of the attached cells
,24 hours after seeding and before resuming perfusion culture.
Phase images across the entire three cell culture chambers per
condition of the microfluidic perfusion device were acquired and
then used to perform image processing. Briefly, phase image
analysis algorithm consists of the following steps: extract bright
morphological features, adjust contrast, threshold, convert to
binary image, and fill holes to calculate the cell area in each image.
The average cell area is obtained by averaging over the entire field
of the cell culture chamber. Percentage of cells expressing Sox1
was assessed similarly, for a particular time point phase and
fluorescence images are analyzed to quantify the total cell area and
area of cells expressing Sox1, respectively. Finally, the ratio of
Sox1 area over the total cell area gave the fraction of cells
expressing Sox1.
Flow cytometry analysis
Cells in static cultures were dissociated using TrypLE Express
(12605-010, Invitrogen, Carlsbad, CA) for 3 minutes, quenched
with media, spun down and resuspended in serum-free medium
supplemented with Propidium Iodide (PI) solution (P4864-10ML,
Sigma-Aldrich) at a concentration of 20 mg/mL. Cells in on-chip
cultures were dissociated using a manually driven syringe
(previously used for cell loading) through cell culture chambers,
filled with different buffers in the following order PBS, 0.25%
Trypsin-EDTA (25200-056, Invitrogen, Carlsbad, CA), and the
culture medium, and spun down after collecting cells in a falcon
tube. Cells resuspended in the medium supplemented with a PI
solution were analyzed using a FACS LSR II (Becton Dickinson,
San Jose, CA).
qRT-PCR analysis
The protocol for harvesting cells from the on-chip cell culture
was same as for flow cytometry. Cells from both static and
perfusion cultures were resuspended in 350 ml cell lysis buffer for
subsequent processing, after trypsinizing and spinning down. Total
RNA was isolated using RNeasyH Plus Microkit (74034, Qiagen,
CA). cDNA was synthesized with DyNAmo
TM cDNA Synthesis
Kit (F-470, Finnzymes, Finland) according to manufacturer’s
instructions. Quantitative real-time PCR reactions were set-up
using DyNAmo
TM SYBRH Green qPCR Kits (F-400, Finnzymes,
Finland) and performed on a MJ Opticon 2 real-time PCR
machine (MJ Research, MA). Quantification of transcript amounts
were based on a standard curve established with cDNA converted
from StratageneH qPCR mouse reference total RNA (750600,
Agilent Technologies, IL). The transcript level of each gene was
normalized to corresponding Gapdh level for a particular sample.
The primers used are listed in Table S1.
Cell counting
For both types of assays, static and on-chip, cells were counted
on a Z2 Coulter Counter (Beckman Coulter, Fullerton, CA) to
obtain cell volume concentration, which was later converted to
equivalent areal density.
Statistical analysis
Statistical analyses were performed using un-paired two-tailed
Student’s t-test assuming samples of equal variance.
Supporting Information
Table S1 Quantitative real-time PCR primer sequences.
(DOCX)
Figure S1 Typical operational modes of the device used in
perfusion experiments. Valves are used in various combinations
throughout different stages of the experiment. Arrows indicate
direction of flow. (1) To load cells, valves are actuated such that all
culture chambers are connected to the cell input without going
thru the bubble traps. (2) Afterward, the valve actuation pattern is
altered to permit flushing of cells in regions of the device except for
the chambers. (3) To permit cell attachment, valves at the
chamber inlets and outlets are closed, preventing any fluid flow
and thus permitting cell attachment. (4) Finally, during culture, the
valves are actuated such that each set of three chambers is
perfused with a different media that traverses the bubble traps.
(TIFF)
Figure S2 Merged phase and fluorescence images of Oct4-GFP
mESCs (Oct4 GFP
+ ABJ1 line) after two days of culture in a
device.
(TIFF)
Figure S3 Relative gene expression in static (N2B27) and
perfused (N2B27+CM) differentiating mESCs cultures. A. Com-
parison of gene expression for early differentiation markers Gata4
(endoderm) and Nkx2.5 (mesoderm) between static and on-chip
cultures. B. Relative gene expression of three genes associated with
self-renewal, in static cultures in N2B27 and N2B27+LIF+BMP4
(N2B27+LB), and perfused cultures in N2B27+CM. Data are
shown as average 6 s.d. from 2 independent experiments, (* Indi-
cates statistical significance, * P,0.05, ** P,0.01, *** P,0.001).
Gene expression is normalized to GAPDH and N2B27 (static
culture) and N2B27+LIF+BMP4 (static culture), in (A) and (B),
respectively.
(TIFF)
Figure S4 Flow cytometric measurement of Sox1-GFP neuronal
precursors frequency upon addition of FGFR inhibitor to both
N2B27 and N2B27+CM in static cultures at different concentra-
tions. A. Relative frequency of Sox1-GFP
+ cells upon addition of
FGFR inhibitor to N2B27 at 100 and 300 ng/mL. B. Relative
frequency of Sox1-GFP
+ cells upon addition of FGFR inhibitor to
N2B27+CM condition at 100 and 300 ng/mL. For both con-
ditions N2B27+FGFRi and N2B27+CM+FGFRi Sox1-GFP
expression is normalized to Sox1 expression of N2B27 and
N2B27+CM condition respectively. Data are average 6 s.d. of 3
independent experiments for (A), and 2 independent experiments
for (B), (* Indicates statistical significance, * P,0.05, ** P,0.01).
Non-GFP expressing D3 mESC line used as a control in flow
cytometry to set the gate.
(TIFF)
Figure S5 Sox1 activation in different conditions in perfusion.
A. Expression of Sox1 protein assessed via image analysis for cells
differentiated in perfusion in N2B27+CM and N2B27+CM+
Microfluidic Control of Diffusible Signaling
PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e22892FGFRi. Data are average 6 s.d. of 3 independent experiments,
(* Indicates statistical significance, *** P,0.001). B. Flow cytometry
profiles of Sox1 activation in N2B27+CM and N2B27+CM+
FGFRi.
(TIF)
Figure S6 A. Photograph of a device clamped into the
microscope stage. B. Schematic of the perfusion setup.
(TIFF)
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